PERK inhibitors
PERK inhibitors are a class of drugs that inhibit the protein kinase PERK. PERK, or Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase, is a type of enzyme that in humans is encoded by the EIF2AK3 gene. It is involved in the Unfolded Protein Response (UPR), a cellular stress response related to the endoplasmic reticulum.
Mechanism of Action[edit | edit source]
PERK inhibitors work by blocking the activity of the PERK enzyme. This enzyme is activated in response to the accumulation of unfolded proteins in the endoplasmic reticulum, a condition known as Endoplasmic Reticulum Stress (ERS). When activated, PERK phosphorylates the eukaryotic initiation factor 2 alpha (eIF2α), leading to a reduction in general protein synthesis but an increase in the translation of specific mRNAs such as ATF4.
By inhibiting PERK, these drugs can potentially modulate the UPR and have therapeutic effects in diseases where ERS and UPR are implicated, such as neurodegenerative diseases, cancer, and diabetes.
Clinical Use[edit | edit source]
Currently, PERK inhibitors are primarily used in research settings. However, they have potential therapeutic applications in a variety of diseases. For example, in neurodegenerative diseases like Alzheimer's disease and Parkinson's disease, PERK inhibition has been shown to reduce neuronal death and improve cognitive and motor function in animal models.
In cancer, PERK activation is often associated with tumor survival and growth, and its inhibition can potentially suppress tumor growth. In diabetes, PERK plays a role in beta-cell dysfunction and death, and its inhibition could potentially protect beta cells and improve insulin secretion.
Side Effects[edit | edit source]
As with any drug, PERK inhibitors can have side effects. These can include nausea, vomiting, diarrhea, and fatigue. More serious side effects can include liver damage and kidney damage. However, these side effects are generally rare and the drugs are generally well tolerated in research settings.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
